Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × OTHER × Locoregional Recurrence × Clear all

Phase

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1208 Neoplasms 954 Prostatic Neoplasms 644 Lung Neoplasms 516 Colorectal Neoplasms 496 Carcinoma, Non-Small-Cell Lung 464 Carcinoma, Hepatocellular 354 Pancreatic Neoplasms 351 Leukemia, Myeloid, Acute 321 Stomach Neoplasms 302 Multiple Myeloma 269 Ovarian Neoplasms 254 Brain Neoplasms 252 Head and Neck Neoplasms 243 Neoplasm Metastasis 226 Precursor Cell Lymphoblastic Leukemia-Lymphoma 224 Rectal Neoplasms 222 Esophageal Neoplasms 221 Uterine Cervical Neoplasms 215 Melanoma 205 Recurrence 195 Squamous Cell Carcinoma of Head and Neck 185 Glioblastoma 183 Lymphoma 182 Sarcoma 179 Urinary Bladder Neoplasms 172 Colonic Neoplasms 169 Glioma 162 Hematologic Neoplasms 153 Triple Negative Breast Neoplasms 152

Interventions

ribociclib 1 exemestane 1 Letrozole 1 Fulvestrant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05467891 2026-02-27

RaPhLRR

Hoosier Cancer Research Network

Phase 2 Recruiting

Locoregional Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡